UM Greece has added pharmaceutical powerhouse Mylan N.V. to its growing list of clients.

Mylan N.V. is a global generic and specialty company registered in the Netherlands. With operational headquarters in Potters Bar in the UK, the company employs over 22,000 worldwide with customers in more than 150 countries. Through a series of strategic acquisitions in 2007, Mylan N.V. grew from the third-largest generic and specialty pharmaceutical company in the U.S. to the second-largest in the world. Currently, the company produces more than 1,000 separate products, with a global manufacturing output of over 45 billion doses annually.

“We are ecstatic that Mylan enlisted UM as a strategic media partner to achieve their business objectives,” said Litsa Megouli, Managing Director, UM Greece. “The market for OTC drugs is developing rapidly and is extremely competitive. We look forward to employing UM’s expertise and innovation to create competitive advantage for such a prestigious client.”

UM’s work for Mylan began on April 1 with the first TV campaign launched on April 20. Congratulations Greece!